Literature DB >> 2884037

Genetic linkage of von Recklinghausen neurofibromatosis to the nerve growth factor receptor gene.

B R Seizinger, G A Rouleau, L J Ozelius, A H Lane, A G Faryniarz, M V Chao, S Huson, B R Korf, D M Parry, M A Pericak-Vance.   

Abstract

von Recklinghausen neurofibromatosis (VRNF) is one of the most common inherited disorders affecting the human nervous system. VRNF is transmitted as an autosomal dominant defect with high penetrance but variable expressivity. The disorder is characterized clinically by hyperpigmented patches of skin (café au lait macules, axillary freckles) and by multiple tumors of peripheral nerve, spinal nerve roots, and brain (neurofibromas, optic gliomas). These tumors can cause disfigurement, paralysis, blindness, and death. We have determined the chromosomal location of the VRNF gene by genetic linkage analysis using DNA markers. The VRNF gene is genetically linked to the locus encoding nerve growth factor receptor, located on the long arm of chromosome 17 in the region 17q12----17q22. However, crossovers with the VRNF locus suggest that a mutation in the nerve growth factor receptor gene itself is unlikely to be the fundamental defect responsible for the VRNF phenotype.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2884037     DOI: 10.1016/0092-8674(87)90534-4

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  77 in total

1.  Transplacental induction of peripheral nervous tumor in the Syrian golden hamster by N-nitroso-N-ethylurea. A new animal model for von Recklinghausen's neurofibromatosis.

Authors:  T Nakamura; M Hara; T Kasuga
Journal:  Am J Pathol       Date:  1989-08       Impact factor: 4.307

2.  Solitary intraosseous neurofibroma: Report of a unique case.

Authors:  Sagar Satish Jangam; Snehal Nilesh Ingole; Mohan Devidas Deshpande; Pallavi Adinath Ranadive
Journal:  Contemp Clin Dent       Date:  2014-10

3.  A genetic study of type 2 neurofibromatosis in the United Kingdom. I. Prevalence, mutation rate, fitness, and confirmation of maternal transmission effect on severity.

Authors:  D G Evans; S M Huson; D Donnai; W Neary; V Blair; D Teare; V Newton; T Strachan; R Ramsden; R Harris
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

Review 4.  Mouse chromosome 11.

Authors:  A M Buchberg; M S Buckwalter; S A Camper
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 5.  Pathogenesis of plexiform neurofibroma: tumor-stromal/hematopoietic interactions in tumor progression.

Authors:  Karl Staser; Feng-Chun Yang; D Wade Clapp
Journal:  Annu Rev Pathol       Date:  2011-11-07       Impact factor: 23.472

Review 6.  Molecular and cellular mechanisms of learning disabilities: a focus on NF1.

Authors:  C Shilyansky; Y S Lee; A J Silva
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

Review 7.  Neuroimaging of phakomatoses: overview and advances.

Authors:  Gilbert Vézina
Journal:  Pediatr Radiol       Date:  2015-09-07

8.  Unusual clustering of brain tumours in a family with NF1 and variable expression of cutaneous features.

Authors:  F Faravelli; M Upadhyaya; M Osborn; S M Huson; R Hayward; R Winter
Journal:  J Med Genet       Date:  1999-12       Impact factor: 6.318

9.  A search for evidence of somatic mutations in the NF1 gene.

Authors:  A M John; M Ruggieri; R Ferner; M Upadhyaya
Journal:  J Med Genet       Date:  2000-01       Impact factor: 6.318

10.  Radiological investigation of neurofibromatosis type 2.

Authors:  P Akeson; S Holtås
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.